FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2003162502> ?p ?o ?g. }

• W2003162502 endingPage "39" @default.
• W2003162502 startingPage "33" @default.
• W2003162502 abstract "Interferon-α (INF-α) has a documented activity against metastic melanoma. To what extent an antiproliferative effect or tumor cell modulation or immunomodulation contributes to this antitumor effect is still uncertain. The role of immune mechanisms in the control of malignant melanoma is suggested by several studies. Therefore, this investigation used monoclonal antibodies, anti-CD4, anti-CD8, and anti-CD11c, to study the occurrence and distribution of tumor-infiltrating mononuclear cells in 10 untreated and 26 IFN-α-treated patients with regional metastatic malignant melanoma. IFN-α was given for 1–3 weeks before resection of the metastases. The infiltration of mononuclear cells in the stroma and close to tumor cells was studied. The duration of IFN-α treatment was found to be of importance for the immunomodulatory effect. In patients treated for ≤1 week, tumor-infiltrating mononuclear cells were still mainly localized in the stroma, similar to the situation in untreated patients. The differences in CD4+ cells close to the tumor cells, comparing untreated patients and patients with various durations of IFN-α treatment, were highly significant (p = 0.009). Thus, IFN-α treatment resulted in recruitment of CD4+ cells close to the tumor cells. IFN-α had only a weak effect on the recruitment of CD8+ and CD11c+ mononuclear cells close to the tumor cells. Regressive changes in metastases were also analyzed and correlated to duration of treatment. Some of the criteria used for histopathologic regression in primary melanoma (distorted histologic architecture, low tumor cell density, and fibrosis) were applied to analyze the effect of IFN-α in metastatic melanoma. The tumor cell density was found to be significantly reduced in metastases with marked tumor regression compared with metastases with no, or only minor, regressive changes (p < 0.005). A chi-square analysis for trend, comparing untreated patients and patients with various durations of IFN-α treatment, showed that regressive changes of the tumor increased significantly during IFN-α treatment (p = 0.02)." @default.
• W2003162502 created "2016-06-24" @default.
• W2003162502 creator A5015469444 @default.
• W2003162502 creator A5043652421 @default.
• W2003162502 creator A5052793138 @default.
• W2003162502 creator A5061611652 @default.
• W2003162502 date "1998-01-01" @default.
• W2003162502 modified "2023-10-16" @default.
• W2003162502 title "Effect of IFN-α on Tumor-Infiltrating Mononuclear Cells and Regressive Changes in Metastatic Malignant Melanoma" @default.
• W2003162502 cites W1573948298 @default.
• W2003162502 cites W1974112602 @default.
• W2003162502 cites W1977140122 @default.
• W2003162502 cites W1985560312 @default.
• W2003162502 cites W1998978540 @default.
• W2003162502 cites W2001658110 @default.
• W2003162502 cites W2005189185 @default.
• W2003162502 cites W2027686867 @default.
• W2003162502 cites W2033207272 @default.
• W2003162502 cites W2037133729 @default.
• W2003162502 cites W2042347911 @default.
• W2003162502 cites W2042630829 @default.
• W2003162502 cites W2042798375 @default.
• W2003162502 cites W2049525098 @default.
• W2003162502 cites W2068716043 @default.
• W2003162502 cites W2078197336 @default.
• W2003162502 cites W2081509224 @default.
• W2003162502 cites W2083574998 @default.
• W2003162502 cites W2089828715 @default.
• W2003162502 cites W2110257105 @default.
• W2003162502 cites W2136320895 @default.
• W2003162502 cites W2335365056 @default.
• W2003162502 cites W4235138555 @default.
• W2003162502 cites W4245517837 @default.
• W2003162502 doi "https://doi.org/10.1089/jir.1998.18.33" @default.
• W2003162502 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9475665" @default.
• W2003162502 hasPublicationYear "1998" @default.
• W2003162502 type Work @default.
• W2003162502 sameAs 2003162502 @default.
• W2003162502 citedByCount "43" @default.
• W2003162502 countsByYear W20031625022012 @default.
• W2003162502 countsByYear W20031625022013 @default.
• W2003162502 countsByYear W20031625022014 @default.
• W2003162502 countsByYear W20031625022016 @default.
• W2003162502 countsByYear W20031625022017 @default.
• W2003162502 countsByYear W20031625022020 @default.
• W2003162502 crossrefType "journal-article" @default.
• W2003162502 hasAuthorship W2003162502A5015469444 @default.
• W2003162502 hasAuthorship W2003162502A5043652421 @default.
• W2003162502 hasAuthorship W2003162502A5052793138 @default.
• W2003162502 hasAuthorship W2003162502A5061611652 @default.
• W2003162502 hasConcept C137061746 @default.
• W2003162502 hasConcept C142724271 @default.
• W2003162502 hasConcept C1491633281 @default.
• W2003162502 hasConcept C167464567 @default.
• W2003162502 hasConcept C167672396 @default.
• W2003162502 hasConcept C17991360 @default.
• W2003162502 hasConcept C202751555 @default.
• W2003162502 hasConcept C203014093 @default.
• W2003162502 hasConcept C204232928 @default.
• W2003162502 hasConcept C2777658100 @default.
• W2003162502 hasConcept C2777701055 @default.
• W2003162502 hasConcept C2778326572 @default.
• W2003162502 hasConcept C502942594 @default.
• W2003162502 hasConcept C52124034 @default.
• W2003162502 hasConcept C54355233 @default.
• W2003162502 hasConcept C55493867 @default.
• W2003162502 hasConcept C71924100 @default.
• W2003162502 hasConcept C86803240 @default.
• W2003162502 hasConcept C8891405 @default.
• W2003162502 hasConceptScore W2003162502C137061746 @default.
• W2003162502 hasConceptScore W2003162502C142724271 @default.
• W2003162502 hasConceptScore W2003162502C1491633281 @default.
• W2003162502 hasConceptScore W2003162502C167464567 @default.
• W2003162502 hasConceptScore W2003162502C167672396 @default.
• W2003162502 hasConceptScore W2003162502C17991360 @default.
• W2003162502 hasConceptScore W2003162502C202751555 @default.
• W2003162502 hasConceptScore W2003162502C203014093 @default.
• W2003162502 hasConceptScore W2003162502C204232928 @default.
• W2003162502 hasConceptScore W2003162502C2777658100 @default.
• W2003162502 hasConceptScore W2003162502C2777701055 @default.
• W2003162502 hasConceptScore W2003162502C2778326572 @default.
• W2003162502 hasConceptScore W2003162502C502942594 @default.
• W2003162502 hasConceptScore W2003162502C52124034 @default.
• W2003162502 hasConceptScore W2003162502C54355233 @default.
• W2003162502 hasConceptScore W2003162502C55493867 @default.
• W2003162502 hasConceptScore W2003162502C71924100 @default.
• W2003162502 hasConceptScore W2003162502C86803240 @default.
• W2003162502 hasConceptScore W2003162502C8891405 @default.
• W2003162502 hasIssue "1" @default.
• W2003162502 hasLocation W20031625021 @default.
• W2003162502 hasLocation W20031625022 @default.
• W2003162502 hasOpenAccess W2003162502 @default.
• W2003162502 hasPrimaryLocation W20031625021 @default.
• W2003162502 hasRelatedWork W2002606273 @default.
• W2003162502 hasRelatedWork W2003162502 @default.
• W2003162502 hasRelatedWork W2321931156 @default.
• W2003162502 hasRelatedWork W2438990667 @default.
• W2003162502 hasRelatedWork W2773127191 @default.

• next